Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

ClinicalTrials.gov ID: NCT00002224

Public ClinicalTrials.gov record NCT00002224. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison of HIV RNA Suppression Produced by Triple Regimens Containing Either Didanosine Enteric Coated or Didanosine Formulations Each Administered Once Daily

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Didanosine is an effective anti-HIV drug, but it can cause stomach upset. This study tests a new form of didanosine, ddI EC, a coated pill that passes through the stomach more easily and hopefully will prevent stomach upset. The purpose of this study is to compare the effectiveness of ddI EC versus the standard form of ddI. Both forms of ddI will be given with stavudine (d4T) plus nelfinavir (NLF).

Study identification

NCT ID
NCT00002224
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
120 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 1999
Primary completion
Feb 28, 1999
Completion
Feb 28, 1999
Last update posted
Apr 24, 2011

1999

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Sorra Research Ctr / Med Forum Birmingham Alabama 35203
AIDS Healthcare Foundation Los Angeles California 900276069
Robert Scott MD Oakland California 94609
Beacon Clinic / Boulder Community Hosp Boulder Colorado 80304
Community Health Care Fort Lauderdale Florida 33306
Immunity Care and Research Inc Fort Lauderdale Florida 33311
HIV Clinical Research Ctr Fort Lauderdale Florida 33316
South Shore Hosp Miami Florida 33139
Saint Josephs Comprehensive Research Institute Tampa Florida 33607
AIDS Research Consortium of Atlanta Atlanta Georgia 303081962
Chicago Ctr for Clinical Research Chicago Illinois 60610
Univ of Kansas School of Medicine Wichita Kansas 672143124
Univ of Nebraska Med Ctr Omaha Nebraska 681985400
Clinical Studies of Las Vegas Las Vegas Nevada 89128
Anderson Clinical Research Inc Rego Park New York 11374
Anderson Clinical Research Inc Reading Pennsylvania 19604
Coastal Carolina Research Ctr Mt. Pleasant South Carolina 29464
Oak Lawn Physicians Group Dallas Texas 75219
Univ of Texas Southwestern Med Ctr of Dallas Dallas Texas 752359103
Nicholaos Bellos Dallas Texas 75246
Houston Clinical Research Network / Div of Montrose Clinic Houston Texas 77006
Swedish Med Ctr Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002224, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2011 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002224 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →